A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants (clinicaltrials.gov) - Mar 18, 2026 - P1 | N=36 | Not yet recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd.
New P1 trial • Cardiomyopathy • Cardiovascular
|